Silje Nord from the Genome variation group, Department of Genetics at the Institute for Cancer Research has been awarded a prestigious career grant from Helse Sør-Øst for the proposal "Making sense of GWAS data". The grant amounts to NOK 2 million per year and runs for 4 years.
Published in major journals, first or last author from Oslo University Hospital.
In Well-Treated Celiac Patients Low-Level Mucosal Inflammation Predicts Response to 14-day Gluten Challenge
Adv Sci (Weinh), 8 (4), 2003526
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
Sci Transl Med, 13 (582)
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
Sci Adv, 7 (8)